P-Flow ₹ 60 Lakhs for 6% Equity Win on Shark Tank India

P-Flow is an innovative urology solution offering a disposable kit for urine flow tests, eliminating the need for frequent hospital visits. This portable kit allows patients to easily conduct Uroflowmetry tests at home, providing results directly to their mobile phones. P-Flow aims to revolutionize urology testing by making it convenient and accessible globally.

Click here to visit their official website: P-Flow

P-Flow is sold online through the company’s website and on Amazon, boasting an impressive accuracy rate of over 95%. It’s priced at around ₹1000, comparable to traditional tests, but since P-Flow can be used three times, it effectively costs around ₹200, resulting in a strong gross margin of about 80%. The product has gained traction, with 650 cases sold in various locations, including the company’s hospital. Projections suggest a potential revenue of 5 lakhs per day. However, due to existing business structures, there may be a need for a new setup, as Dr. Ashish Rawandale’s intellectual property and patents for this product are under his personal name rather than his publicly listed company with 125 crores in revenue.

Related: Medtech Startup Qure.ai Raises $65 Mn to Fund Product Development and Expansion

Dr. Ashish Patil is a very skilled doctor who has achieved remarkable things. He holds the Guinness World Record two times, which shows that he’s done something exceptional. Specifically, he’s removed a very large number of stones from people’s kidneys, and he’s also performed an operation to draw the biggest kidney.

P-Flow Business is a company that focuses on innovation, and they’ve worked on 43 new ideas. They also own 18 patents, which means they have legal rights to some of their unique inventions. When they work, they do so with 95% accuracy, which is very precise. They offer a package of three tests for ₹1000 and have sold 650 sets of these tests, which shows that their work is valued.

Amit Jain and Namita wanted to invest in a company because they thought it could make a big impact worldwide. But they wanted to change how the company was organized and the rights it had for its inventions. They first suggested giving the company 60 lakh rupees in exchange for 10% ownership, but the company’s leaders, Peyush, Anupam, and Aman, all had issues with how complicated the deal was. The company asked for some time to think about it, but Namita said they couldn’t change the offer.

Then the company offered to give them 3% ownership, but Namita didn’t like that and asked for 8%. The company said no to that too. Anupam asked if there was any room to talk about it, and the company said a little. Finally, Amit suggested giving them 60 lakh rupees for 6% ownership, and the company said yes to that.

Based on our investigation, we found out that the agreement with the investors known as the sharks didn’t go through. It seems that instead of setting up new companies for P-Flow, the business owners chose to launch it under their current company called ‘Tejnaksh Healthcare.’ According to the latest report we have, the company earned a total revenue of 12.03 crores in the financial year 2022-2023 with a net profit of 1.79 crores. However, in the previous financial year 2021-2022, their revenue was higher at 12.82 crores, and they made profits of 2.81 crores.